VRAX icon

Virax Biolabs
VRAX

Overview Fund Activity

7 hedge funds and large institutions have $81.8K invested in Virax Biolabs in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

Holders
7
Holders Change
+4
Holders Change %
+133.33%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VF
1
Virtu Financial
New York
$33K
2
HF
2
HRT Financial
New York
$29K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$12.8K
4
UBS Group
4
UBS Group
Switzerland
$6.5K
5
Qube Research & Technologies (QRT)
5
Qube Research & Technologies (QRT)
United Kingdom
$348

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
VF
1
Virtu Financial
New York
$33K +$33K +28,058 New
HF
2
HRT Financial
New York
$29K +$29K +25,672 New
Renaissance Technologies
3
Renaissance Technologies
New York
$12.8K +$12.8K +11,001 New
UBS Group
4
UBS Group
Switzerland
$6.5K +$3.51K +3,026 +118%
Qube Research & Technologies (QRT)
5
Qube Research & Technologies (QRT)
United Kingdom
$348 +$348 +300 New
Wells Fargo
6
Wells Fargo
California
$116 – – –
HT
7
Headlands Technologies
Illinois
$52 +$52 +45 New
Citadel Advisors
8
Citadel Advisors
Florida
– -$10.6K -14,785 Closed